CHICAGO--(BUSINESS WIRE)--Therapeutic Proteins International, LLC (TPI), a US based biosimilars company, received the ‘Innovation of the Year’ award sponsored by Honeywell at the Global Generics and Biosimilars Awards held in Paris on Oct. 7, 2014. The accolade recognized TPI’s significant accomplishments in biopharmaceutical manufacturing and continued commitment to innovation in the industry.
TPI has employed innovation to streamline the manufacturing process for recombinant drugs. With dozens of patented and proprietary technologies, TPI’s process leverages single-use bioreactors which reduce the risk of cross contamination, increase consistency and optimize cost and scalability. The patents range from single container manufacturing, wherein both upstream and downstream processes are combined, to aeration systems that allow for fermentation of bacterial culture in a closed single-use bioreactor creating a system suitable for the production of both cytokines and monoclonal antibodies.